MAM
TDI looks to capture burgeoning outdoor ad market
New Delhi: Ad agency TDI which has been associated with Airport advertising for the last 17 years is looking to spread its wings.
TDI claims to be the largest out of home media ownership company with exclusive advertising rights of 17 prime airports in the country. It has expanded its wings by launching a new division TDI Media Services.
An official release informs that this division of TDI International India will provide 360 degrees media solution to all its clients across the country. The initiative will kick off with Out Of Home Media solutions by way of strategic planning, buying, creative consultancy and solutions, state of art execution and installation, proactive maintenance, constant monitoring and post-buy analysis.
The release states that outdoor advertising is going through a metamorphosis as clients look for more value from their ad spends. Like the competition TDI Media Services aims at maximising the advertising results of every penny spent by their clients.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
